Omics for Health

ABOUT GENEPLUS

Leading Precision Medicine Company

GenePlus is a leading AI-powered precision medicine company. Leveraging our AI-driven multi-omics technology platform, we have built end-to-end capabilities spanning biomarker and target discovery and validation, product development, and commercialization. We focus on three key application areas: precision diagnostics, AI-enabled drug discovery, and clinical research and translation, pioneering a new AI-driven paradigm for precision medicine.

11TH

Founded in 2015

30+Provinces &Municipalities

Domestic Reach

10+Countries

Global Footprint

Products and Solutions

View Details

Focusing on clinical and industrial needs, we deliver our core capabilities across three key application areas, providing customized solutions for hospitals, pharmaceutical and biotechnology companies, and medical research institutions.

View Details

Precision Diagnostics Solutions
Centered on the innovative application of NGS, we have built a fully automated platform with integrated solutions for multiple applications.
View Details
Drug R&DEnablement Solutions
Focused on companion diagnostics, we deliver end-to-end clinical trial solutions for new drugs, including biomarker discovery and validation, patient screening, and virtual patient solutions.
View Details
Clinical Research and Translation Solutions
Centered on AI-powered multi-omics, we have built an AI4S collaboration platform for disease biomarker and target discovery and validation.
View Details

Item 2 of 3

Precision Diagnostics Solutions
Centered on the innovative application of NGS, we have built a fully automated platform with integrated solutions for multiple applications.
View Details
Drug R&D Enablement Solutions
Focused on companion diagnostics, we deliver end-to-end clinical trial solutions for new drugs, including biomarker discovery and validation, patient screening, and virtual patient solutions.
View Details
Clinical Research and Translation Solutions
Centered on AI-powered multi-omics, we have built an AI4S collaboration platform for disease biomarker and target discovery and validation.
View Details

Item 2 of 3

Precision DiagnosticsSolutions

Centered on the innovative application of NGS, we have built a fully automated platform with integrated solutions for multiple applications.

View Details

Precision Diagnostics Solutions

Drug R&DEnablement Solutions

Focused on companion diagnostics, we deliver end-to-end clinical trial solutions for new drugs, including biomarker discovery and validation, patient screening, and virtual patient solutions.

View Details

Drug R&D Enablement Solutions

Clinical Research andTranslationSolutions

Centered on AI-powered multi-omics, we have built an AI4S collaboration platform for disease biomarker and target discovery and validation.

View Details

Clinical Research and Translation Solutions

The Entire Chain of Innovation and Transformation

Powered by our in-house AI-integrated multi-omics platform, we deliver an end-to-end framework from biomarker discovery and validation through product development to commercialization, enabling precision medicine innovation from bench to market.

Biomarker/Target Discovery & Validation

Fuse multimodal data to identify and prioritize actionable biomarker/target candidates.

AI Multi-Omics Infrastructure

Our AI multi-omics platform is built on three tightly coupled modules: Omics Research Services, the Bioinformatics Cloud & Database, and Foundation Models & Agents. Together they form a closed-loop technology foundation spanning the full workflow from data generation and multimodal data analysis to AI-driven biomarker discovery and validation, continuously fueling a growing ecosystem of new AI applications.